MARC details
000 -LEADER |
fixed length control field |
04367nam a22005055i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085931.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
221027s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783031093883 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-031-09388-3 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
TR-AnTOB |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WR 165 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MJK |
Source |
bicssc |
|
Subject category code |
MED017000 |
Source |
bisacsh |
|
Subject category code |
MJK |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WR165EBK |
245 10 - TITLE STATEMENT |
Title |
Drug Eruptions |
Medium |
[electronic resource] / |
Statement of responsibility, etc. |
edited by Haur Yueh Lee, Daniel Creamer. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
490 1# - SERIES STATEMENT |
Series statement |
Updates in Clinical Dermatology, |
International Standard Serial Number |
2523-8892 |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Section I: General Considerations -- Chapter 1: Pharmacogenetics of Cutaneous Adverse Drug Reactions -- Chapter 2: Mechanisms of Drug Hypersensitivity -- Chapter 3: Histopathology of Cutaneous Adverse Drug Reactions -- Chapter 4: Skin Tests in Evaluating Drug Eruptions -- Chapter 5: In vitro Drug Allergy Testing -- Section II: Reaction Patterns -- Chapter 6: Drug-induced urticaria -- Chapter 7: Exanthematous Drug Eruptions -- Chapter 8: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis -- Chapter 9: Acute Generalized Exanthematous Pustulosis -- Chapter 10: Drug Reaction Eosinophilia and Systemic Symptoms (DRESS) -- Chapter 11: Fixed Drug Eruptions and Generalized Bullous Fixed Drug Eruptions -- Chapter 12: Lichenoid Drug Eruptions -- Chapter 13: Drug-induced Connective Tissue Disorders -- Chapter 14: Drug-induced Vasculitis -- Chapter 15: Drug-induced Autoimmune Bullous Diseases -- Chapter 16: Other Drug-induced Inflammatory Skin Reactions -- Chapter 14: Drug-induced Vasculitis -- Chapter 15: Drug-induced Autoimmune Bullous Diseases -- Chapter 16: Other Drug-induced Inflammatory Skin Reactions -- Chapter 17: Drug-induced Photosensitivity -- Chapter 18: Drug-induced Pruritus Without Primary Rash -- Chapter 19: Drug-induced Nail Changes -- Chapter 20: Drug-induced Hair Changes -- Chapter 21: Drug-induced Pigmentary Disorders -- Section III: Special Drug Categories -- Chapter 22: Immediate and Delayed Reactions to Beta-lactams -- Chapter 23: Hypersensitivity Reactions to Iodinated Radiocontrast Media -- Chapter 24: Cutaneous Adverse Reactions to Biologic Agents -- Chapter 25: Cutaneous Reactions to Oncologic Targeted Therapy -- Chapter 26 :Cutaneous Reactions to Oncologic Immunotherapy. . |
520 ## - SUMMARY, ETC. |
Summary, etc. |
Cutaneous adverse drug reactions are common and range from the benign to those which are life-threatening. The clinical presentation of these dermatoses is varied and many may mimic common skin conditions. Consequently, diagnosis in drug-induced skin disease is challenging and the treatment considerations are complex. This book aims to bridge the divide between dermatology and allergy by providing a comprehensive review on the pathomechanisms and clinical features of cutaneous adverse drug reactions. Broken up into three distinct sections: General Considerations, Reaction Patterns, and Special Drug Categories, these chapters cover the common and rare adverse skin reactions and provide information on recent advances - particularly immunopathology and pharmacogenetics - as well as highlighting new adverse drug signals and novel therapies. Drug Eruptions is a must-have resource for dermatologists, allergists, internal physicians and general practitioners. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Dermatology. |
|
Topical term or geographic name entry element |
Allergy. |
|
Topical term or geographic name entry element |
Dermatology. |
|
Topical term or geographic name entry element |
Allergology. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Drug Eruptions |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Lee, Haur Yueh. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Creamer, Daniel. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Updates in Clinical Dermatology, |
International Standard Serial Number |
2523-8892 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-031-09388-3">https://doi.org/10.1007/978-3-031-09388-3</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |